Ebola Vaccine Sterility Claims: The Conspiracy That Endangers Public Health

The primary Ebola vaccine, rVSV-ZEBOV (marketed as Ervebo), was approved by the FDA on December 19, 2019, and received conditional marketing authorization from the European Medicines Agency on November 11, 2019. ^{[2] [3]}

Both the FDA's prescribing information and the EMA's product information for Ervebo state plainly that there are no dedicated human fertility studies for the vaccine — but neither found any signal of fertility harm in the nonclinical data submitted for approval. EMA's product information states that Ervebo "administered to female rats had no effects on mating performance, fertility, or embryonic/foetal development," and that animal studies "do not indicate direct or indirect harmful effects with respect to reproductive toxicity." ^[3]

The FDA label likewise reports that "ERVEBO administered to female rats had no effects on fertility," while noting the vaccine has not been separately evaluated for effects on male fertility. ^[2]

On the human side, the FDA label cites a pooled clinical-trial safety database of 18,817 participants who received at least one dose of Ervebo, with no fertility-related adverse signal reported among them. ^[2] The landmark Guinea "Ebola Ça Suffit!" ring-vaccination trial, published in The Lancet, found the vaccine highly effective and generally well-tolerated — but it excluded pregnant women from vaccination and did not specifically assess reproductive outcomes, so it cannot be read as direct trial evidence on fertility; that evidence comes from the nonclinical data above. ^[4]

Since approval, Ervebo has been deployed at scale in outbreak responses. An analysis of the 2018–2020 DRC outbreak estimated that roughly 330,000 people in the affected provinces were vaccinated in 2019 and 2020 alone. ^[6] A separate analysis of the ring-vaccination campaign in that same outbreak, published in the *New England Journal of Medicine, put the total at 265,183 vaccinated participants*, with active safety follow-up on a subset of them, and concluded that "no safety concerns with the vaccine were identified." ^[5]

Beyond that outbreak, the CDC reports that more than 145,000 additional doses have been shipped from the International Coordinating Group's vaccine stockpile since 2021 for use in subsequent Ebola responses. ^[14] No fertility-related safety signal has emerged from any of this real-world use.

The Ebola vaccine sterility claim did not emerge in isolation — it echoes a decades-old pattern of vaccine-sterility rumors in Africa. In 1994, the US-based anti-contraception group Human Life International began promoting the false claim, since repeatedly debunked by the WHO and independent laboratory testing, that tetanus vaccines were secretly laced with a fertility-blocking hormone; Africa Check has documented that this specific rumor has persisted for more than 25 years despite the repeated debunking. ^[9]

Researchers who study this mistrust trace part of it to real historical grievances, including coercive, unconsented colonial-era medical campaigns carried out in Central Africa. Those historical abuses are real, but they do not make current, internationally reviewed vaccines dangerous. ^[10]

A template for vaccine-sterility rumors was set in 2003, when religious and political leaders in five northern Nigerian states boycotted the oral polio vaccine, alleging without evidence that it was contaminated with "anti-fertility agents", along with HIV and cancer-causing agents. ^[7]

Vaccination was suspended for close to a year while a Nigerian government technical committee arranged for vaccine samples to be independently tested; a delegation of state and religious representatives traveled to observe testing in South Africa, Indonesia, and India and returned satisfied with the vaccine's safety, after which the boycott was resolved in 2004. ^[7]

Fear of infertility has been directly linked to reduced vaccine acceptance during outbreak responses. In the North Kivu survey cited above, the infertility rumor was among the most common pieces of negative information reported by community members who were offered the vaccine. ^[11]

Humanitarian responders tracked this dynamic in real time: the UN's OCHA-run Centre for Humanitarian Data reported that community-feedback systems set up during the DRC outbreak had logged more than 350,000 individual pieces of community feedback — including rumors, beliefs, questions, and concerns — by August 2019, information responders used to target their engagement with affected communities. ^[12]

The DRC's 2018–2020 outbreak, which this misinformation complicated, was at the time the second-largest Ebola outbreak ever recorded, with 3,481 cases and 2,299 deaths. ^{[1] [6]}

New Ebola outbreaks in Uganda (2025) and the Democratic Republic of the Congo (2026) have again put the disease in the headlines. ^[1] The North Kivu survey data show the infertility rumor was still a live part of community discourse about the vaccine as recently as 2021, well after the vaccine's approval — there is no evidence the underlying myth has gone away, even as the specific claims circulating in any single outbreak shift with the news cycle. ^[11]

No regulator, clinical trial, or peer-reviewed nonclinical study has found evidence that Ebola vaccines cause infertility or sterility. The FDA, the EMA, and the trial and post-marketing record described above are consistent on this point. ^{[1] [2] [3] [4]}

African fact-checking organizations have a long track record of investigating and debunking vaccine-sterility rumors built on the same template now applied to Ebola vaccines — including Africa Check's investigation of the still-circulating, 25-year-old false claim that tetanus vaccines cause infertility. ^[9]

Outbreak responders have built community-engagement and rumor-tracking systems specifically to counter claims like the infertility rumor, including the OCHA feedback system in DRC that logged over 350,000 pieces of community input by August 2019 to help target misinformation responses. ^[12]

Aid organizations including Médecins Sans Frontières have emphasized that ring vaccination — offering the vaccine to the contacts and contacts-of-contacts of confirmed cases — depends on community trust to succeed, which is part of why addressing rumors directly, rather than dismissing them, has become central to outbreak response strategy. ^[13]

The claim that Ebola vaccines cause sterility is FALSE.

No peer-reviewed clinical trial, nonclinical safety study, or regulatory review has found evidence that Ervebo or other Ebola vaccines cause infertility. Animal studies conducted for FDA and EMA licensing found no effect on fertility, and hundreds of thousands of doses have been administered in real-world outbreak responses with no fertility-related safety signal reported. ^{[2] [3] [5] [6]}

The myth follows a well-documented template of vaccine-sterility rumors in Africa — including the 2003 Nigeria polio vaccine boycott and a still-circulating false claim about tetanus vaccines — that draws on legitimate historical grievances about colonial-era medical abuse even though it has no basis in the current vaccine's actual safety record. ^{[7] [9] [10]}

Its spread has been measurably linked, in DRC survey data, to lower trust in and slower uptake of a vaccine that has otherwise been shown safe and highly effective against a disease that kills a large share of the people it infects. ^{[8] [11]}

For accurate information on Ebola vaccines, consult the WHO Ebola page or the FDA's ERVEBO prescribing information.